electroCore Inc. (ECOR)
| Bid | 7.47 |
| Market Cap | 54.56M |
| Revenue (ttm) | 25.18M |
| Net Income (ttm) | -11.89M |
| EPS (ttm) | -1.59 |
| PE Ratio (ttm) | -4.77 |
| Forward PE | 82.11 |
| Analyst | Buy |
| Ask | 7.72 |
| Volume | 51,093 |
| Avg. Volume (20D) | 151,944 |
| Open | 7.32 |
| Previous Close | 7.36 |
| Day's Range | 7.16 - 7.70 |
| 52-Week Range | 5.02 - 19.49 |
| Beta | 0.84 |
About ECOR
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or i...
Analyst Forecast
According to 2 analyst ratings, the average rating for ECOR stock is "Buy." The 12-month stock price forecast is $25.5, which is an increase of 236.19% from the latest price.
Stock Forecasts
1 week ago · proactiveinvestors.co.uk
Ecora Resources expects stronger Q2 after solid start to 2025Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) has posted what it described as a “solid start” to the year, reporting a $6 million portfolio contribution in the first quarter of 2025, down from...
1 month ago · proactiveinvestors.co.uk
Ecora eyes strong 2025 as copper and cobalt streams ramp upEcora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) is expecting a sharp increase in royalty income in 2025, driven by rising production volumes across its copper and cobalt assets and supported by ...
2 months ago · proactiveinvestors.co.uk
Ecora Resources landed a significant copper deal - ICYMIEcora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) this week unveiled a significant new deal that promises to elevate its commodity diversification efforts to a new level. It is acquiring an intere...
